Illumina's Annual Profit Forecast Continues to Decline
TL;DR Summary
Illumina, a leading genomics company, has lowered its annual profit forecast for the second consecutive quarter due to supply chain disruptions and increased competition. The company's shares fell by 10% following the announcement.
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 2 min read
Condensed
91%
356 → 33 words
Want the full story? Read the original article
Read on Yahoo Finance